Versameb is developing a new technology platform for local protein delivery through mRNA induction in multiple disease areas, focusing first on regenerative medicine.
Products, services, technology
VERSAMEB's platform has produced candidates that are at an advanced preclinical stage.
Cooperation possibilities
Versameb is willing to exploit the potential of its proprietary platform with renowned pharmaceutical and biotech companies.